Vitamin C, Quo Vadis?
- PMID: 34078847
- DOI: 10.1097/PCC.0000000000002718
Vitamin C, Quo Vadis?
Conflict of interest statement
Dr. Sanchez-Pinto’s institution received money from the National Institutes of Health and the National Institute for Child Health and Human Development. Dr. Wald has disclosed that he does not have any potential conflicts of interest.
Comment on
-
Efficacy and Safety of Parenteral High-Dose Vitamin C Therapy in Pediatric Patients: A Scoping Review.Pediatr Crit Care Med. 2021 Jun 1;22(6):561-571. doi: 10.1097/PCC.0000000000002686. Pediatr Crit Care Med. 2021. PMID: 33729732
Similar articles
-
[Vitamin D--quo vadis?].Ugeskr Laeger. 2004 May 10;166(20):1919-20. Ugeskr Laeger. 2004. PMID: 15202387 Danish. No abstract available.
-
[Vitamin C].Rev Prat. 2013 Oct;63(8):1091-6. Rev Prat. 2013. PMID: 24298827 Review. French.
-
Vitamin C status and physical working capacity in adolescents.Int J Vitam Nutr Res. 1984;54(1):55-60. Int J Vitam Nutr Res. 1984. PMID: 6735616
-
Stopped-flow investigation of the reaction between vitamin E radical and vitamin C in solution.Biochem Biophys Res Commun. 1987 Jul 15;146(1):134-9. doi: 10.1016/0006-291x(87)90701-7. Biochem Biophys Res Commun. 1987. PMID: 3606612
-
Ascorbic acid and atherosclerotic cardiovascular disease.Subcell Biochem. 1996;25:331-67. doi: 10.1007/978-1-4613-0325-1_17. Subcell Biochem. 1996. PMID: 8821982 Review.
References
-
- Yanase F, Raman S, Naorungroj T, et al.: Efficacy and Safety of Parenteral High-Dose Vitamin C Therapy in Pediatric Patients: A Scoping Review. Pediatr Crit Care Med 2021; 22:561–571
-
- De Grooth H, Spoelstra-de Man A, Oudemans-van Straaten H: Early plasma vitamin C concentration, organ dysfunction and ICU mortality [abstract 0723]. Intensive Care Med 2014; 40:S199
-
- Borrelli E, Roux-Lombard P, Grau GE, et al.: Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med 1996; 24:392–397
-
- Fowler AA 3rd, Syed AA, Knowlson S, et al.; Medical Respiratory Intensive Care Unit Nursing: Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis. J Transl Med 2014; 12:32
-
- Zabet MH, Mohammadi M, Ramezani M, et al.: Effect of high-dose ascorbic acid on vasopressor’s requirement in septic shock. J Res Pharm Pract 2016; 5:94–100
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical